Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis—ABCD-10
Author(s) -
Megan H. Noe,
Misha Rosenbach,
Rebecca A. Hubbard,
Arash Mostaghimi,
Adela R. Cardones,
Jennifer K. Chen,
Jonathan Cotliar,
Mark D.P. Davis,
Arturo R. Domínguez,
Lindy P. Fox,
Lauren C. Hughey,
Benjamin H. Kaffenberger,
Daniela Kroshinsky,
Bernice Y. Kwong,
Daniel D. Miller,
Amy Musiek,
Alex G. OrtegaLoayza,
Victoria R. Sharon,
Kanade Shinkai,
Erika M. Summers,
Karolyn A. Wanat,
David A. Wetter,
Scott Worswick,
David J. Margolis,
Joel M. Gelfand,
Robert G. Micheletti
Publication year - 2019
Publication title -
jama dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.128
H-Index - 166
eISSN - 2168-6084
pISSN - 2168-6068
DOI - 10.1001/jamadermatol.2018.5605
Subject(s) - toxic epidermal necrolysis , medicine , mucocutaneous zone , cohort , medical record , odds ratio , emergency medicine , mortality rate , cohort study , retrospective cohort study , receiver operating characteristic , pediatrics , dermatology , disease
Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is a spectrum of severe mucocutaneous drug reaction associated with significant morbidity and mortality. A previously developed SJS/TEN-specific severity-of-illness model (Score of Toxic Epidermal Necrolysis [SCORTEN]) has been reported to overestimate and underestimate SJS/TEN-related in-hospital mortality in various populations.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom